The current study has illustrated that uridine is capable of exerting potential therapeutic and anti-inflammatory effects on Inflammatory Bowel Disease (IBD) by modulating slc10a2. These findings could offer a novel therapeutic target for the intervention of IBD. This evidence concerns the gene SLC10A2 and inflammatory bowel disease.